Please Wait.....
Report
Asia Pacific Glycomic Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - Class (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher's Disease, MPS-1 & IV, Cancer, Alzheimer's Disease, Influenza Type A & B, and Others), Mode of Action [Inhibits Neuraminidase, Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate, Erythropoietin & Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthas Interleukin 1 and 2 and 3, Beta & Gamma Interferons, and Others]
Market Report I 2022-11-18 I 210 Pages I The Insight Partners
The glycomic therapeutics market in Asia Pacific is expected to grow from US$ 12.95 billion in 2022 to US$ 34.59 billion by 2028; it is estimated to grow at a CAGR of 17.8% from 2022 to 2028.
Wide Applications of Glycomics in Therapeutics to Provide Lucrative Opportunities for Market Growth
Glycomics is a novel method for creating medicines. It draws on the knowledge that glycans serve as the primary means of altering numerous molecules in biological systems. This alteration provides those molecules with their complete, functional form. Glycans are found in most top-selling biologics and half of the therapeutic proteins, including antibodies against COVID-19. Glycans of these proteins have been tailored to improve their effectiveness, lower the dosages required, and lessen negative effects. For instance, understanding the biological functions of glycans has led to their inclusion as essential ingredients in medications for the treatment of diabetes, the prevention of blood clotting, and the improvement of in vitro fertilization. Changes in the glycans on a microbe's surface are frequently connected to the microorganisms' resistance to popular medications. This property is used for detecting particular glycans in infection samples, disabling the protective biofilms formed by the infecting bacteria, and weakening the glycan-rich cell walls of microorganisms. More than 130 uncommon genetic illnesses, many of which are fatal in childhood, are brought on by errors. Understanding the glycans responsible for a few of these problems has helped develop therapies. Since glycans can play a crucial role in studying attacks of bacteria and viruses on the immune systems of humans, they are employed in vaccinations. Additionally, recent research on SARS-CoV-2, which causes COVID-19, has shown infection pathways that depend on the virus's usage of human glycans. Glycomics has the potential to bring new perspectives to precision medicine, which is currently dominated by genetic and proteomic tools. Therefore, the high adoption of glycomics in various therapeutic areas would propel the demand for these techniques in the coming years. Nonetheless, ongoing research and developments and clinical advancements in the field of therapeutics are expected to create lucrative growth opportunities for the glycomics therapeutics market during the forecast period.
Market Overview
Asia Pacific (APAC) is the fastest-growing market for glycomic therapeutics. The Asia Pacific glycomics therapeutics market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Asia Pacific is likely to account for ~11.89% share of the global glycomic therapeutics market in 2022 owing to the improving government support in countries, collaboration of research organizations, rising glycomics research institutes, and advancing healthcare infrastructure. Therefore, the region offers several opportunities for the glycomic therapeutics market players to grow during the forecast period.
Asia Pacific Glycomic Therapeutics Market Revenue and Forecast to 2028 (US$ Billion)
Asia Pacific Glycomic Therapeutics Market Segmentation
The Asia Pacific glycomic therapeutics market is segmented on the basis of class, structure, indications, mode of action, and country.
Based on class, the Asia Pacific glycomic therapeutics market is bifurcated into isolated and synthetic. The synthetic segment registered a larger market share in 2022. Based on structure, the Asia Pacific glycomic therapeutics market is segmented into glycoproteins, targeting sialic acid, proteoglycans, targeting glycosaminoglycans, glycosylphosphatidylinositol (GPI)-anchored proteins & heparin based glycans, targeting glycosphingolipids, and others. The glycoproteins segment held the largest market share in 2022. Based on indications, the Asia Pacific glycomic therapeutics market is segmented into thrombosis & chemoprophylaxis, anaemia, anti-adhesive & anti-inflammatory, cataracts, gaucher's disease, MPS-1 & IV, cancer, alzheimer's disease, influenza type A & B, and others. The influenza type a & b segment held the largest market share in 2022. Based on mode of action, the Asia Pacific glycomic therapeutics market is segmented into inhibits neuraminidase, inhibits heparanase and selectins and blocks interactions between growth factors and heparan sulfate, erythropoietin & enzyme replacement therapy (ERT), tissue plasminogen activator, inhibits glucosylceramide synthase, interleukin 1 and 2 and 3, beta & gamma interferons, and others. The erythropoietin & enzyme replacement therapy (ERT) segment held the largest market share in 2022. Based on country, the Asia Pacific glycomic therapeutics market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the market in 2022. BioMarinPharmaceuticalInc.;GenzymeCorporation(Sanofi);BayerAG;Alzheon,Inc.;GlaxoSmithKline plc.; and F. Hoffmann-La Roche Ltd. are the leading companies operating in the glycomic therapeutics in Asia Pacific.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Glycomic Therapeutics Market - By Class
1.3.2 Asia Pacific Glycomic Therapeutics Market - By Structures
1.3.3 Asia Pacific Glycomic Therapeutics Market - By Indications
1.3.4 Asia Pacific Glycomic Therapeutics Market - By Mode of Action
1.3.5 Asia Pacific Glycomic Therapeutics Market - By Country
2. Asia Pacific Glycomic Therapeutics Market- Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Glycomic Therapeutics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific - PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Glycomic Therapeutics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Wide Application in Various Disorders Followed by the Development of New Treatment Processes
5.1.2 Increasing Research and Development In the Field of Glycomic Therapeutics
5.2 Market Restraints
5.2.1 Shortage of Skilled Professionals and Lack of Research & Development laboratories in Developing Countries.
5.3 Market Opportunities
5.3.1 Wide Applications of Glycomics in Therapeutics
5.4 Future Trends
5.4.1 New Tools in Glycomics Research
5.5 Impact Analysis
6. Glycomic Therapeutics Market- Asia Pacific Analysis
6.1 Asia Pacific Glycomic Therapeutics Market Revenue Forecast and Analysis
6.1.1 Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, (US$ Million)
7. Asia Pacific Glycomic Therapeutics Market Revenue and Forecast to 2028- by Class
7.1 Overview
7.2 Asia Pacific Glycomic Therapeutics Market, By Class 2022 & 2028 (%)
7.2.1 Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Class (US$ Million)
7.3 Isolated
7.3.1 Overview
7.3.2 Asia Pacific Isolated Revenue and Forecast to 2028 (US$ Million)
7.4 Synthetic
7.4.1 Overview
7.4.2 Asia Pacific Synthetic - Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Glycomics Therapeutics Market Analysis and Forecasts To 2028 - By Indication
8.1 Overview
8.2 Asia Pacific Glycomics Market, By Indication 2022 & 2028 (%)
8.2.1 Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Indications (US$ Million)
8.3 Thrombosis and Chemoprophylaxis
8.3.1 Overview
8.3.2 Asia Pacific Thrombosis and chemoprophylaxis Revenue and Forecast to 2028 (US$ Million)
8.4 Anaemia
8.4.1 Overview
8.4.2 Asia Pacific Anaemia Revenue and Forecast to 2028 (US$ Million)
8.5 Anti-adhesive and Anti-inflammatory
8.5.1 Overview
8.5.2 Asia Pacific Anti-adhesive and Anti-inflammatory Revenue and Forecast to 2028 (US$ Million)
8.6 Cataract
8.6.1 Overview
8.6.2 Asia Pacific Cataract Revenue and Forecast to 2028 (US$ Million)
8.7 Gaucher's diseases
8.7.1 Overview
8.7.2 Asia Pacific Gaucher's diseases Revenue and Forecast to 2028 (US$ Million)
8.8 MPS-1 & IV
8.8.1 Overview
8.8.2 Asia Pacific MPS-1 & IV Revenue and Forecast to 2028 (US$ Million)
8.9 Cancer
8.9.1 Overview
8.9.2 Asia Pacific Cancer Revenue and Forecast to 2028 (US$ Million)
8.10 Alzheimer's
8.10.1 Overview
8.10.2 Asia Pacific Alzheimer's Revenue and Forecast to 2028 (US$ Million)
8.11 Influenza Type A and B
8.11.1 Overview
8.11.2 Asia Pacific Influenza Type A and B Revenue and Forecast to 2028 (US$ Million)
8.12 Others
8.12.1 Overview
8.12.2 Asia Pacific Others Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Glycomic Therapeutics Market Revenue and Forecast to 2028 - by Structures
9.1 Overview
9.2 Asia Pacific Glycomic Therapeutics Market, By Structures 2022 & 2028 (%)
9.2.1 Asia Pacific: Glycomic Therapeutics Market, by Structures, 2019-2028 (US$ Million)
9.2.1.1 Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Sialic Acid (US$ Million)
9.2.1.2 Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosaminoglycans (US$ Million)
9.2.1.3 Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosphingolipids (US$ Million)
9.2.1.4 Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Others (US$ Million)
9.3 Glycoproteins
9.3.1 Overview
9.3.2 Asia Pacific Glycoproteins - Market Revenue and Forecast to 2028 (US$ Million)
9.4 Targeting Sialic Acid
9.4.1 Overview
9.4.2 Asia Pacific Targeting Sialic Acid - Market Revenue and Forecast to 2028 (US$ Million)
9.4.3 Zanamivir
9.4.3.1 Overview
9.4.3.2 Asia Pacific Zanamivir - Market Revenue and Forecast to 2028 (US$ Million)
9.4.4 Oseltamivir
9.4.4.1 Overview
9.4.4.2 Asia Pacific Oseltamivir - Market Revenue and Forecast to 2028 (US$ Million)
9.5 Proteoglycans
9.5.1 Overview
9.5.2 Asia Pacific Proteoglycans - Market Revenue and Forecast to 2028 (US$ Million)
9.6 Glycosylphosphatidylinositol (GPI)-Anchored Proteins and Heparin Based Glycans
9.6.1 Overview
9.6.2 Asia Pacific Glycosylphosphatidylinositol (GPI)-Anchored Proteins and Heparin Based Glycans - Market Revenue and Forecast to 2028 (US$ Million)
9.7 Targeting Glycosaminoglycans
9.7.1 Overview
9.7.2 Asia Pacific Targeting Glycosaminoglycans - Market Revenue and Forecast to 2028 (US$ Million)
9.7.3 Heparin
9.7.3.1 Overview
9.7.3.2 Asia Pacific Heparin - Market Revenue and Forecast to 2028 (US$ Million)
9.7.4 Hyaluronan (HA)
9.7.4.1 Overview
9.7.4.2 Asia Pacific Hyaluronan (HA)- Market Revenue and Forecast to 2028 (US$ Million)
9.7.5 Laronidase
9.7.5.1 Overview
9.7.5.2 Asia Pacific Laronidase - Market Revenue and Forecast to 2028 (US$ Million)
9.7.6 Galsulfase (Naglazyme)
9.7.6.1 Overview
9.7.6.2 Asia Pacific Galsulfase (Naglazyme) - Market Revenue and Forecast to 2028 (US$ Million)
9.7.7 Hyaluronidase (Cumulase)
9.7.7.1 Overview
9.7.7.2 Asia Pacific Hyaluronidase (Cumulase) - Market Revenue and Forecast to 2028 (US$ Million)
9.7.8 Others
9.7.8.1 Overview
9.7.8.2 Asia Pacific Others - Market Revenue and Forecast to 2028 (US$ Million)
9.8 Targeting Glycosphingolipids
9.8.1 Overview
9.8.2 Asia Pacific Targeting Glycosphingolipids - Market Revenue and Forecast to 2028 (US$ Million)
9.8.3 Imiglucerase (Cerezyme)
9.8.3.1 Overview
9.8.3.2 Asia Pacific Imiglucerase (Cerezyme)- Market Revenue and Forecast to 2028 (US$ Million)
9.8.3.3 Agalsidase (Fabrazyme)
9.8.3.3.1 Overview
9.8.3.3.2 Asia Pacific Agalsidase (Fabrazyme) - Market Revenue and Forecast to 2028 (US$ Million)
9.8.3.4 N-butyl-deoxynojirimycin (DNJ)
9.8.3.4.1 Overview
9.8.3.4.2 Asia Pacific N-butyl-deoxynojirimycin (DNJ) - Market Revenue and Forecast to 2028 (US$ Million)
9.8.4 Others
9.8.4.1 Overview
9.8.4.2 Asia Pacific Others - Market Revenue and Forecast to 2028 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Asia Pacific Others - Market Revenue and Forecast to 2028 (US$ Million)
9.9.3 Acarbose
9.9.3.1 Overview
9.9.3.2 Asia Pacific Acarbose - Market Revenue and Forecast to 2028 (US$ Million)
9.9.3.3 Alglucosidase Alfa (Myozyme)
9.9.3.3.1 Overview
9.9.3.3.2 Asia Pacific Alglucosidase Alfa (Myozyme) - Market Revenue and Forecast to 2028 (US$ Million)
9.9.3.4 Allosamidin
9.9.3.4.1 Overview
9.9.3.4.2 Asia Pacific Allosamidin - Market Revenue and Forecast to 2028 (US$ Million)
9.9.4 Others
9.9.4.1 Overview
9.9.4.2 Asia Pacific Others - Market Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Glycomic Therapeutics Market Revenue and Forecast to 2028 - by Mode of Action
10.1 Overview
10.2 Asia Pacific Glycomic Therapeutics Market, By Mode of Action 2022 & 2028 (%)
10.2.1 Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Mode of Action (US$ Million)
10.3 Inhibits Neuraminidase
10.3.1 Overview
10.3.2 Asia Pacific Inhibits Neuraminidase - Market Revenue and Forecast to 2028 (US$ Million)
10.4 Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate
10.4.1 Overview
10.4.2 Asia Pacific Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate - Market Revenue and Forecast to 2028 (US$ Million)
10.5 Erythropoietin And Enzyme Replacement Therapy (ERT)
10.5.1 Overview
10.5.2 Asia Pacific Erythropoietin And Enzyme Replacement Therapy (ERT) - Market Revenue and Forecast to 2028 (US$ Million)
10.6 Tissue Plasminogen Activator
10.6.1 Overview
10.6.2 Asia Pacific Tissue Plasminogen Activator - Market Revenue And Forecasts To 2028 (US$ Million)
10.7 Inhibits Glucosylceramide Synthase
10.7.1 Overview
10.7.2 Asia Pacific Inhibits Glucosylceramide Synthase - Market Revenue And Forecasts To 2028 (US$ Million)
10.8 Interleukin 1 And 2 And 3
10.8.1 Overview
10.8.2 Asia Pacific Interleukin 1 And 2 And 3- Market Revenue And Forecasts To 2028 (US$ Million)
10.9 Beta And Gamma Interferons
10.9.1 Overview
10.9.2 Asia Pacific Beta And Gamma Interferons- Market Revenue And Forecasts To 2028 (US$ Million)
10.10 Others
10.10.1 Overview
10.10.2 Asia Pacific Others- Market Revenue And Forecasts To 2028 (US$ Million)
11. Asia Pacific Glycomic Therapeutics Market Revenue and Forecasts to 2028 - Country Analysis
11.1 Asia Pacific Glycomic Therapeutics Market Revenue and Forecasts To 2028
11.1.1 Overview
11.1.2 Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Country (%)
11.1.2.1 China: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.1.1 Overview
11.1.2.1.2 China: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.1.3 China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Class (US$ Million)
11.1.2.1.4 China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, by Structures, 2019-2028 (US$ Million)
11.1.2.1.4.1 China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Sialic Acid (US$ Million)
11.1.2.1.4.2 China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosaminoglycans (US$ Million)
11.1.2.1.4.3 China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosphingolipids (US$ Million)
11.1.2.1.4.4 China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Others (US$ Million)
11.1.2.1.5 China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Indications (US$ Million)
11.1.2.1.6 China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Mode of Action (US$ Million)
11.1.2.2 Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.2.1 Overview
11.1.2.2.2 Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.2.3 Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Class (US$ Million)
11.1.2.2.4 Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, by Structures, 2019-2028 (US$ Million)
11.1.2.2.4.1 Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Sialic Acid (US$ Million)
11.1.2.2.4.2 Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosaminoglycans (US$ Million)
11.1.2.2.4.3 Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosphingolipids (US$ Million)
11.1.2.2.4.4 Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Others (US$ Million)
11.1.2.2.5 Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Indications (US$ Million)
11.1.2.2.6 Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Mode of Action (US$ Million)
11.1.2.3 India Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.3.1 Overview
11.1.2.3.2 India: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.3.3 India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Class (US$ Million)
11.1.2.3.4 India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, by Structures, 2019-2028 (US$ Million)
11.1.2.3.4.1 India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Sialic Acid (US$ Million)
11.1.2.3.4.2 India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosaminoglycans (US$ Million)
11.1.2.3.4.3 India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosphingolipids (US$ Million)
11.1.2.3.4.4 India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Others (US$ Million)
11.1.2.3.5 India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Indications (US$ Million)
11.1.2.3.6 India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Mode of Action (US$ Million)
11.1.2.4 South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.4.1 Overview
11.1.2.4.2 South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.4.3 South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Class (US$ Million)
11.1.2.4.4 South Korea: Glycomic Therapeutics Market, by Structures, 2019-2028 (US$ Million)
11.1.2.4.4.1 South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Sialic Acid (US$ Million)
11.1.2.4.4.2 South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosaminoglycans (US$ Million)
11.1.2.4.4.3 South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosphingolipids (US$ Million)
11.1.2.4.4.4 South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Others (US$ Million)
11.1.2.4.5 South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Indications (US$ Million)
11.1.2.4.6 South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Mode of Action (US$ Million)
11.1.2.5 Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.5.1 Overview
11.1.2.5.2 Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
11.1.2.5.3 Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Class (US$ Million)
11.1.2.5.4 Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, by Structures, 2019-2028 (US$ Million)
11.1.2.5.4.1 Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Sialic Acid (US$ Million)
11.1.2.5.4.2 Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosaminoglycans (US$ Million)
11.1.2.5.4.3 Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosphingolipids (US$ Million)
11.1.2.5.4.4 Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Others (US$ Million)
11.1.2.5.5 Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Indications (US$ Million)
11.1.2.5.6 Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Mode of Action (US$ Million)
11.1.2.6 Rest of Asia Pacific: Glycomic Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.2.6.1 Overview
11.1.2.6.2 Rest of Asia Pacific: Glycomic Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.2.6.3 Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Class (US$ Million)
11.1.2.6.4 Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, by Structures, 2019-2028 (US$ Million)
11.1.2.6.4.1 Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Sialic Acid (US$ Million)
11.1.2.6.4.2 Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosaminoglycans (US$ Million)
11.1.2.6.4.3 Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosphingolipids (US$ Million)
11.1.2.6.4.4 Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Others (US$ Million)
11.1.2.6.5 Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Indications (US$ Million)
11.1.2.6.6 Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Mode of Action (US$ Million)
12. Glycomic Therapeutics Market -Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Glycomic Therapeutics Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 BioMarin Pharmaceutical Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Genzyme Corporation (Sanofi)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Bayer AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 GlaxoSmithKline plc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms in Glycomic Therapeutics Market
LIST OF TABLES
Table 1. Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, (US$ Million).
Table 2. Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Class (US$ Million).
Table 3. Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Indications (US$ Million)
Table 4. Asia Pacific: Glycomic Therapeutics Market, by Structures - Revenue and Forecast to 2028 (US$ Million)
Table 5. Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Sialic Acid (US$ Million)
Table 6. Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosaminoglycans (US$ Million)
Table 7. Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosphingolipids (US$ Million)
Table 8. Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Others (US$ Million)
Table 9. Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Mode of Action (US$ Million)
Table 10. China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Class (US$ Million).
Table 11. China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, by Structures - Revenue and Forecast to 2028 (US$ Million)
Table 12. China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Sialic Acid (US$ Million)
Table 13. China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosaminoglycans (US$ Million)
Table 14. China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosphingolipids (US$ Million)
Table 15. China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Others (US$ Million)
Table 16. China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Indications (US$ Million)
Table 17. China: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Mode of Action (US$ Million)
Table 18. Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Class (US$ Million).
Table 19. Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, by Structures - Revenue and Forecast to 2028 (US$ Million)
Table 20. Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Sialic Acid (US$ Million)
Table 21. Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosaminoglycans (US$ Million)
Table 22. Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosphingolipids (US$ Million)
Table 23. Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Others (US$ Million)
Table 24. Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Indications (US$ Million)
Table 25. Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Mode of Action (US$ Million)
Table 26. India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Class (US$ Million).
Table 27. India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, by Structures - Revenue and Forecast to 2028 (US$ Million)
Table 28. India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Sialic Acid (US$ Million)
Table 29. India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosaminoglycans (US$ Million)
Table 30. India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosphingolipids (US$ Million)
Table 31. India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Others (US$ Million)
Table 32. India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Indications (US$ Million)
Table 33. India: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Mode of Action (US$ Million)
Table 34. South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Class (US$ Million).
Table 35. South Korea: Glycomic Therapeutics Market, by Structures - Revenue and Forecast to 2028 (US$ Million)
Table 36. South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Sialic Acid (US$ Million)
Table 37. South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosaminoglycans (US$ Million)
Table 38. South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosphingolipids (US$ Million)
Table 39. South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Others (US$ Million)
Table 40. South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Indications (US$ Million)
Table 41. South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Mode of Action (US$ Million)
Table 42. Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Class (US$ Million).
Table 43. Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, by Structures - Revenue and Forecast to 2028 (US$ Million)
Table 44. Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Sialic Acid (US$ Million)
Table 45. Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosaminoglycans (US$ Million)
Table 46. Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosphingolipids (US$ Million)
Table 47. Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Others (US$ Million)
Table 48. Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Indications (US$ Million)
Table 49. Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Mode of Action (US$ Million)
Table 50. Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Class (US$ Million).
Table 51. Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, by Structures - Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Sialic Acid (US$ Million)
Table 53. Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosaminoglycans (US$ Million)
Table 54. Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Targeting Glycosphingolipids (US$ Million)
Table 55. Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Others (US$ Million)
Table 56. Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Indications (US$ Million)
Table 57. Rest of Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Mode of Action (US$ Million)
Table 58. Organic Developments in the Glycomic Therapeutics Market
Table 59. Inorganic Developments in the Glycomic Therapeutics Market
Table 60. Glossary of Terms in Glycomic Therapeutics Market
LIST OF FIGURES
Figure 1. Asia Pacific Glycomic Therapeutics Market Segmentation
Figure 2. Asia Pacific Glycomic Therapeutics Market, By Country
Figure 3. Asia Pacific Glycomic Therapeutics Market Overview
Figure 4. Synthetic Segment Held Largest Share of Class Segment in Asia Pacific Glycomic Therapeutics Market
Figure 5. India is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Asia Pacific Glycomic Therapeutics Market Impact Analysis of Driver and Restraints
Figure 8. Asia Pacific Glycomics market - Revenue Forecast And Analysis - 2020- 2028
Figure 9. Asia Pacific Glycomic Therapeutics Market, by Class 2022 & 2028 (%)
Figure 10. Asia Pacific Isolated Revenue and Forecasts to 2028 (US$ Million)
Figure 11. Asia Pacific Synthetic - Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Asia Pacific Glycomics Market, by Indication 2022 & 2028 (%)
Figure 13. Asia Pacific Thrombosis and chemoprophylaxis Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Asia Pacific Anaemia Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Asia Pacific Anti-adhesive and Anti-inflammatory Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Asia Pacific Cataract Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Asia Pacific Gaucher's diseases Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Asia Pacific MPS-1 & IV Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Asia Pacific Cancer Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Asia Pacific Alzheimer's Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Asia Pacific Influenza Type A and B Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Asia Pacific Others Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Asia Pacific Glycomic Therapeutics Market, by Structures 2022 & 2028 (%)
Figure 24. Asia Pacific Glycoproteins - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Asia Pacific Targeting Sialic Acid - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Asia Pacific Zanamivir - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Asia Pacific Oseltamivir - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Asia Pacific Proteoglycans - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Asia Pacific Glycosylphosphatidylinositol (GPI)-Anchored Proteins and Heparin Based Glycans - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Asia Pacific Targeting Glycosaminoglycans - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Asia Pacific Heparin - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Asia Pacific Hyaluronan (HA)- Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. Asia Pacific Laronidase - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. Asia Pacific Galsulfase (Naglazyme) - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Asia Pacific Hyaluronidase (Cumulase) - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Asia Pacific Others - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. Asia Pacific Targeting Glycosphingolipids - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. Asia Pacific Imiglucerase (Cerezyme) - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. Asia Pacific Agalsidase (Fabrazyme) - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 40. Asia Pacific N-butyl-deoxynojirimycin (DNJ) - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 41. Asia Pacific Others - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 42. Asia Pacific Others - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 43. Asia Pacific Acarbose - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 44. Asia Pacific Alglucosidase Alfa (Myozyme) - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 45. Asia Pacific Allosamidin - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 46. Asia Pacific Others - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 47. Asia Pacific Glycomic Therapeutics Market, by Mode of Action 2022 & 2028 (%)
Figure 48. Asia Pacific Inhibits Neuraminidase - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 49. Asia Pacific Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 50. Asia Pacific Erythropoietin And Enzyme Replacement Therapy (ERT) - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 51. Asia Pacific Tissue Plasminogen Activator - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 52. Asia Pacific Inhibits Glucosylceramide Synthase - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 53. Asia Pacific Interleukin 1 And 2 And 3- Market Revenue And Forecasts To 2028 (US$ Million)
Figure 54. Asia Pacific Beta And Gamma Interferons - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 55. Asia Pacific Others - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 56. Asia Pacific: Glycomic Therapeutics Market Overview, by Country (2022)
Figure 57. Asia Pacific: Glycomic Therapeutics Market Revenue and Forecasts to 2028, By Country (%)
Figure 58. China: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 59. Japan: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 60. India: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 61. South Korea: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 62. Australia: Glycomic Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 63. Rest of Asia Pacific: Glycomic Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 64. Growth Strategies in the Glycomic Therapeutics Market (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security